Merck KGaA (FRA: MRK)‘s stock had its “underweight” rating restated by equities researchers at Barclays Capital in a report issued on Monday. They currently have a $110.13 (€85) price target on the stock.

Other equities research analysts have also recently issued reports about the stock. Analysts at JPMorgan Chase reiterated a “neutral” rating on shares of Merck KGaA in a research note to investors on Thursday. They now have a $125.97 price target on the stock. Separately, analysts at Independent Research GmbH reiterated a “sell” rating on shares of Merck KGaA in a research note to investors on Wednesday. They now have a $123.68 price target on the stock. Finally, analysts at AlphaValue reiterated a “sell” rating on shares of Merck KGaA in a research note to investors on Thursday, November 29th. They now have a $113.64 price target on the stock.

Merck KGaA traded up 3.54% on Monday, hitting €106.50. Merck KGaA has a 52-week low of €72.00 and a 52-week high of €103.00.

.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.